Africa & Middle East

Companies can now settle renewal fees through structured payment plans, with options to extend payments until 30 September 2026.

The government has set a bold target: by 2030, Egypt will manufacture 140 million human vaccine doses per year.

The South African Health Products Regulatory Authority officially approved Lenacapavir, branded as Sunlenca, on October 27, 2025, making South Africa the first African country to authorize this innovation.

The donation includes a hydraulic integrated operating table, a stainless steel instrument table, a manual wheelchair, and a surgical operating lamp.

Both nations will work together to strengthen their health information systems through coordinated collection, analysis, and sharing of epidemiological data, scientific research findings, and public health intelligence.

SPARK-NCD addresses undiagnosed high blood pressure or diabetes by improving monitoring systems, training a skilled public health team, and integrating chronic disease information into current national health systems.

Histotripsy uses precisely focused ultrasound energy to destroy tumours from outside the body, eliminating the need for surgery, radiotherapy, or chemotherapy.

The Amyaz Award specifically honours organisations that demonstrate leadership and drive measurable improvements in patient safety and care delivery.

The initiative recognizes that pharmacists serve as critical figures in healthcare, often representing the first and most accessible point of contact for millions of Egyptians seeking guidance on everyday health concerns.

The partnership seeks to unify healthcare data and convert it into actionable insights that healthcare providers, insurance companies, and government agencies can leverage.